publication venue for
- 2023 AACC Annual Scientific Meeting Abstracts: Elevating and Disseminating Science to the Next Level. 2023
- Generalizability of a Machine Learning Model for Improving Utilization of Parathyroid Hormone-Related Peptide Testing across Multiple Clinical Centers. 2023
- Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma.. 68. 2022
- Measurement Biases Distort Cell-Free DNA Fragmentation Profiles and Define the Sensitivity of Metagenomic Cell-Free DNA Sequencing Assays. 2021
- TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability.. 67. 2021
- Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning.. 66. 2020
- Inadequate Reporting of Analytical Characteristics of Biomarkers Used in Clinical Research: A Threat to Interpretation and Replication of Study Findings.. 65. 2019
- Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis.. 65. 2019
- High-Sensitivity Cardiac Troponin I as a Gatekeeper for Coronary Computed Tomography Angiography and Stress Testing in Patients with Acute Chest Pain.. 63. 2017
- Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.. 63. 2016
- Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study.. 63. 2016
- Gene expression profiling of circulating tumor cells in breast cancer.. 61. 2014
- Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy.. 58. 2012
- The need for standardization of tacrolimus assays.. 57. 2011
- Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study.. 57. 2011
- Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial.. 56. 2010
- Understanding resistance to tamoxifen in hormone receptor-positive breast cancer.. 55. 2009
- Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.. 55. 2009
- A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples.. 53. 2007
- Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.. 53. 2006
- Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells.. 49. 2003
- Detection of cystic fibrosis mutations by peptide mass signature genotyping.. 49. 2003
- Rapid detection of the C-1496G polymorphism in the CYP2D6 *2 allele.. 47. 2001
- Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen.. 45. 1999
- Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects.. 45. 1999
- Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer.. 45. 1999
- Automated measurement of mouse apolipoprotein B: convenient screening tool for mouse models of atherosclerosis.. 43. 1997
- Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma.. 43. 1997
- Denaturing gradient gel electrophoresis to diagnose multiple endocrine neoplasia type 2.. 42. 1996
- Nighttime dosing assures postdistribution sampling for therapeutic drug monitoring of digoxin.. 42. 1996
- Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens.. 39. 1993
- Radioimmunoassay of inhibin based on synthetic human inhibin alpha-chain peptide.. 37. 1991
- Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma.. 36. 1990
- Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method.. 35. 1989
- A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma.. 35. 1989
- Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-I in plasma.. 34. 1988
- Three methods compared for determination of pancreatic and salivary amylase activity in serum of cystic fibrosis patients.. 32. 1986
- Monoclonal antibodies can precipitate low-density lipoprotein. I. Characterization and use in determining apolipoprotein B.. 31. 1985
- Reference intervals for amylase isoenzymes in serum and plasma of infants and children.. 29. 1983
- Sickle cell crisis as evaluated from measurements of hydroxybutyrate dehydrogenase and myoglobin in plasma.. 27. 1981
- Quantitative gel-electrophoretic determination of serum amylase isoenzyme distributions.. 25. 1979
- Direct spectrophotometric determination of alpha-amylase activity in salive, with p-nitrophenyl alpha-maltoside as substrate.. 23. 1977
- Fragment Size Analysis May Distinguish Clonal Hematopoiesis from Tumor-Derived Mutations in Cell-Free DNA.. 66. 2020
- Commentary.. 64. 2018
- Detrimental Effects of Not Using International Reference Materials to Calibrate Cystatin C Assays.. 62. 2015
- Use of potassium concentrations as a quality-of-service metric for phlebotomists detects systematic preanalytical biases and facilitates their correction.. 60. 2014
- Plasma renin activity enzyme-kinetic assay: protection of Angiotensin I from bacterial degradation.. 57. 2010
- Triglyceride interference with an immunoturbidimetric quantification of lipoprotein(a) in serum.. 40. 1994
- Lipid factors as predictors of coronary disease.. 39. 1993
- Argument in favor of using mass units to calibrate and report concentrations of human choriogonadotropin.. 32. 1986
- Toward Standardization of Preanalytical Procedures for Cell-Free DNA Profiling.. 66. 2020
- Incorporating Clinical Considerations into Statistical Analyses of Markers: A Quiet Revolution in How We Think About Data.. 62. 2016
- Detection of androgen receptor mutations in circulating tumor cells: highlights of the long road to clinical qualification.. 56. 2010
- Cutpoints in clinical chemistry: time for fundamental reassessment.. 55. 2008
- Should we measure asymmetric dimethylarginine in patients with coronary artery disease?. 53. 2007
- Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. 2016